157537 Social Solidarity vs Actuarial Fairness in Health Reform

Tuesday, November 6, 2007: 3:20 PM

Wendy K. Mariner, JD, LLM, MPH , Health Law, Bioethics and Human Rights, Boston University School of Public Health, Boston, MA
Health reform proposals, from the “Massachusetts model” to federal initiatives, vacillate between a social solidarity model, with the goal of universal access to care, and an actuarial fairness model, which matches insurance coverage and price to individual health risks. On the one hand, most U.S. proposals purport to provide insurance coverage (not necessarily health care) to almost everyone, without regard to individual health status, reflecting the social solidarity model. On the other hand, many current proposals condition access to care or the price of insurance benefits on indicators of health status, such as age or compliance with wellness programs, consistent with models of actuarial fairness. Since each model rests on fundamentally different premises, the presence of both in any health reform initiative may invite irreconcilable conflicts in cost and coverage. This presentation evaluates the use of both models in current health reform laws and initiatives, including Massachusetts Chapter 58 and Senator Wyden's Healthy Americans Act. It suggests a method for identifying the elements of each model in health reform proposals and for determining the extent to which each serves specific goals of health reform, from universal access to care to assigning personal responsibility for health risks.

Learning Objectives:
Recognize the characteristics of health reform proposals that support social solidarity and actuarial fairness, respectively Identify and describe the difference between social solidarity and actuarial fairness

Keywords: Health Reform, Health Insurance

Presenting author's disclosure statement:

Any relevant financial relationships? No
Any institutionally-contracted trials related to this submission?

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

See more of: Health Insurance Reform
See more of: Health Law